CN Patent

CN104288143A — 复方格隆溴铵甲硫酸新斯的明注射液及其制备方法

Assigned to Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd · Expires 2015-01-21 · 11y expired

What this patent protects

本发明提供了一种稳定的复方格隆溴铵甲硫酸新斯的明注射液及其制备方法。该注射液附加剂由枸橼酸及枸橼酸钠组成的缓冲液、稳定剂三水合醋酸钠和等渗调节剂氯化钠组成,本发明注射液的pH值是3.5~4.0,在热压灭菌下,有关物质基本不增加,在贮存过程中未出现pH值下降、溶液颜色变黄、可见异物检查不合格、有关物质检查不合格的问题,可以保证产品符合药品质量标准的规定,便于临床用药和推广。

USPTO Abstract

本发明提供了一种稳定的复方格隆溴铵甲硫酸新斯的明注射液及其制备方法。该注射液附加剂由枸橼酸及枸橼酸钠组成的缓冲液、稳定剂三水合醋酸钠和等渗调节剂氯化钠组成,本发明注射液的pH值是3.5~4.0,在热压灭菌下,有关物质基本不增加,在贮存过程中未出现pH值下降、溶液颜色变黄、可见异物检查不合格、有关物质检查不合格的问题,可以保证产品符合药品质量标准的规定,便于临床用药和推广。

Drugs covered by this patent

Patent Metadata

Patent number
CN104288143A
Jurisdiction
CN
Classification
Expires
2015-01-21
Drug substance claim
No
Drug product claim
No
Assignee
Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.